Clene Inc. Profile Avatar - Palmy Investing

Clene Inc.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, incl…

Biotechnology
US, Salt Lake City [HQ]

Resulting Ratios

7 Records · Starting from 2017
Loading...
End of CLNN's Analysis
CIK: 1822791 CUSIP: 185634102 ISIN: US1856341029 LEI: - UEI: -
Secondary Listings
CLNN has no secondary listings inside our databases.